Rita Andraos
Impact in
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 2
- Epigenetics and DNA Methylation 1
- Kruppel-like factors research 1
- Genetics 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
- Genetic Syndromes and Imprinting 1
- Co-authors
- Thomas Radimerski (6 shared papers)Vincent Romanet (5 shared papers)Masato Murakami (5 shared papers)Ina Klebba (1 shared paper)Adrian Britschgi (2 shared papers)Urs Müller (2 shared papers)Heike Brinkhaus (2 shared papers)Mohamed Bentires‐Alj (2 shared papers)
- Journals
- Blood (2 papers)Cancer Cell (1 paper)Proceedings of the National Academy of Sciences (1 paper)Clinical Cancer Research (1 paper)BMC Cancer (1 paper)
- Partner nations
- SwitzerlandUnited StatesSweden
In The Last Decade
Rita Andraos
7 papers receiving 422 citations
Peers
Comparison fields: 5 of 51
- Genetics 124
- Hematology 92
- Oncology 117
- Molecular Biology 264
- Cancer Research 40
Countries citing papers authored by Rita Andraos
This map shows the geographic impact of Rita Andraos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Andraos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Andraos more than expected).
Fields of papers citing papers by Rita Andraos
This network shows the impact of papers produced by Rita Andraos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Andraos. The network helps show where Rita Andraos may publish in the future.
Co-authors
The 25 scholars most cited alongside Rita Andraos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 199 | |
| 2 | 2007 | 88 | |
| 3 | 2013 | 60 | |
| 4 | 2012 | 34 | |
| 5 | 2011 | 22 | |
| 6 | 2011 | 22 | |
| 7 | 2013 | 1 |
About Rita Andraos
Rita Andraos is a scholar working on Molecular Biology, Genetics, Oncology, Pathology and Forensic Medicine and Hematology, having authored 7 papers that have together received 426 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Cytokine Signaling Pathways and Interactions (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Cancer Mechanisms and Therapy (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Epigenetics and DNA Methylation (1 paper), Genetic Syndromes and Imprinting (1 paper) and Kruppel-like factors research (1 paper). The work is most often cited by research in Genetics (124 citations), Hematology (92 citations), Oncology (117 citations), Molecular Biology (264 citations) and Cancer Research (40 citations). Rita Andraos has collaborated with scholars based in Switzerland, United States and Sweden. Frequent co-authors include Thomas Radimerski, Vincent Romanet, Masato Murakami, Ina Klebba, Adrian Britschgi, Urs Müller, Heike Brinkhaus, Mohamed Bentires‐Alj, Fabienne Baffert and Nicolas Ebel. Their work appears in journals such as Blood, Cancer Cell, Proceedings of the National Academy of Sciences, Clinical Cancer Research and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.